In plain terms: The FDA authorizes e-cigarette products through the PMTA (Premarket Tobacco Product Application) process. As of September 2026, 48 products from 5 brands (Vuse, NJOY, Logic, JUUL, and Glas) have received FDA marketing authorization. The VapeScan Study did not distinguish between FDA-authorized and unauthorized products — it measured vaping behavior in general. State laws may further restrict which products are legal to sell. See our [state flavor ban guide](vape-flavor-bans-by-state-2026-complete-guide) for details.
- FDA PMTA authorization does not mean a product is safe — it means the FDA determined that allowing the product on the market is "appropriate for the protection of public health." The VapeScan findings may influence future FDA regulatory decisions.
- State laws vary widely. California bans all disposable vapes (AB 762). Seventeen states maintain PMTA product directories. Texas bans Chinese-made vapes. Check your state's laws before purchasing.
- The American Heart Association has called for more research on vaping's cardiovascular effects. The VapeScan Study directly responds to this call.
- Nicotine is the likely mechanism for the blood pressure effect. Nicotine acutely raises blood pressure and heart rate by activating the sympathetic nervous system. The VapeScan findings suggest this acute effect may become chronic with long-term vaping.
FDA Status: As of September 14, 2026, 48 vape products from 5 brands have received FDA PMTA marketing authorization. The VapeScan Study measured vaping behavior in general and did not distinguish between authorized and unauthorized products. State laws may independently restrict product availability.
